1. Assessment
A documented view of the current position: regulatory status, operational performance, quality exposure and vendor relationships.
Solutions · Clinical Development Consulting | Strategic Advisory | Guosa Life Sciences
Clinical Development Consulting for an Evolving Research Landscape
Clinical development has become increasingly complex. Sponsors must navigate evolving regulatory expectations, decentralized research models, digital transformation, global operational challenges and growing demands for quality, efficiency and innovation.
Overview
Guosa Life Sciences provides strategic consulting that helps organizations address these challenges through evidence-based planning, multidisciplinary expertise and practical implementation strategies.
Our consultants strengthen decision-making, improve operational performance, optimize quality systems and accelerate successful clinical development.

Capabilities
The GLS Advantage
Every solution delivered by Guosa Life Sciences is strengthened by the broader enterprise. Our operational teams are supported by evidence-based Insights, professional development through GLS Academy, collaborative partnerships within the Clinical Development Network and a quality-driven delivery model, enabling scientifically sound, operationally efficient and scalable solutions.
The capability
We advise on the decisions that shape a program before execution begins, and we intervene when execution has gone wrong. That covers country and site selection, feasibility modeling, operating model design, vendor selection and oversight, due diligence, and trial rescue where a study is behind plan or a quality position has deteriorated.
Rescue work is diagnostic before it is corrective. A study behind on recruitment, a TMF that will not survive inspection and a vendor relationship that has broken down look similar from the outside and require different responses. The first deliverable is an assessment that says plainly which problem is actually present.
Regulatory considerations
Country selection is a regulatory decision as much as an operational one. Approval timelines, joint review eligibility, local representation requirements, permit lead times and data transfer restrictions differ enough between candidate countries to change an activation plan by months. Modeling these at feasibility rather than discovering them at start-up is the single highest-return piece of advisory work on most programs.
Where a program is already in difficulty, the regulatory position usually needs assessment first. Amendments filed inconsistently across countries, safety reports submitted to some authorities and not others, and approvals that have lapsed during a pause are common findings, and they constrain what remediation options remain open.
How an engagement runs
A documented view of the current position: regulatory status, operational performance, quality exposure and vendor relationships.
Realistic paths forward with cost, timeline and risk attached to each, including the option of stopping.
An agreed plan with owners, dates and decision points.
Implementation support to the depth the sponsor wants, from advisory oversight to embedded delivery.
What you receive
A documented assessment of the current position. Costed options with timeline and risk. An agreed plan with owners and decision points. Implementation support to the agreed depth.
Evidence and context
Our operating assumptions are published rather than asserted. The Future of Clinical Trials in Africa sets out why study performance is increasingly determined by ecosystem maturity rather than site selection, and The Untapped Advantage makes the case that institutions, not regions, are the right unit of qualification. Both are available in full, with executive briefs for readers who want the argument in a shorter form.
FAQ
Sponsors, biotechs, governments, NGOs and healthcare institutions, from early-stage companies to established organizations expanding into new regions.
Yes. Advisory naturally connects to our integrated Solutions, so strategy transitions smoothly into execution when you're ready.
Tell us about your objectives and our multidisciplinary team will scope an integrated, flexible solution.